BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20431368)

  • 1. Is there a role for leukotriene antagonists in the prevention of recurrent nasal polyps?
    Rasp G
    Curr Opin Allergy Clin Immunol; 2010 Jun; 10(3):200-5. PubMed ID: 20431368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments.
    Nathan RA
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):182-90; quiz 190-1, 232. PubMed ID: 12602664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azelastine and olopatadine in the treatment of allergic rhinitis.
    Kaliner MA
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):373-80. PubMed ID: 19927534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class.
    Benninger M; Farrar JR; Blaiss M; Chipps B; Ferguson B; Krouse J; Marple B; Storms W; Kaliner M
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):13-29. PubMed ID: 20143641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
    Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.
    Schapowal AG; Simon HU; Schmitz-Schumann M
    Acta Otorhinolaryngol Belg; 1995; 49(3):235-50. PubMed ID: 7484142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological modulation of the leukotriene pathway in allergic airway disease.
    Montuschi P; Sala A; Dahlén SE; Folco G
    Drug Discov Today; 2007 May; 12(9-10):404-12. PubMed ID: 17467577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism.
    Ciprandi G; Tosca MA; Milanese M; Schenone G; Ricca V
    Eur Ann Allergy Clin Immunol; 2004 Feb; 36(2):67-70, 72. PubMed ID: 15061398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotriene receptor antagonists: clinical potential in allergic rhinitis.
    Diamant Z; Fokkens WJ
    Rhinology; 2001 Dec; 39(4):187-90. PubMed ID: 11826686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC; Bachert C
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal persistent inflammation, an emerging concept in the nature and treatment of allergic rhinitis: the possible role of leukotrienes.
    Storms WW
    Ann Allergy Asthma Immunol; 2003 Aug; 91(2):131-40. PubMed ID: 12952106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal allergy.
    Frankland AW
    Aviat Space Environ Med; 1984 May; 55(5):425-8. PubMed ID: 6145407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W; Diez Crespo CD; Bähre M
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis.
    Wilson AM; O'Byrne PM; Parameswaran K
    Am J Med; 2004 Mar; 116(5):338-44. PubMed ID: 14984820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of nasal inflammation and nasal airflow with forced expiratory volume in 1 second in patients with perennial allergic rhinitis and asthma.
    Ciprandi G; Cirillo I; Vizzaccaro A; Milanese M; Tosca MA
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):575-80. PubMed ID: 15609768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of leukotrienes and the effect of leukotriene receptor antagonists in allergic rhinitis].
    Kupryś I; Kuna P
    Pol Merkur Lekarski; 2000 Oct; 9(52):717-20. PubMed ID: 11144066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of leukotriene inhibitors in allergic rhinitis and paranasal sinusitis.
    Parnes SM
    Curr Allergy Asthma Rep; 2002 May; 2(3):239-44. PubMed ID: 11918866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allergic rhinitis and asthma: pathophysiological relationship and implications for treatment].
    Diamant Z; Tarasevych S; Chandoesing P; van Wijk RG; de Groot H
    Ned Tijdschr Geneeskd; 2006 Jan; 150(2):77-82. PubMed ID: 16440561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cellular staging for the severity of chronic rhinosinusitis.
    Kountakis SE; Arango P; Bradley D; Wade ZK; Borish L
    Laryngoscope; 2004 Nov; 114(11):1895-905. PubMed ID: 15510011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caring for patients with allergic rhinitis.
    Hayden ML; Womack CR
    J Am Acad Nurse Pract; 2007 Jun; 19(6):290-8. PubMed ID: 17535338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.